Catatonia in a hospitalized patient with COVID-19 and proposed immune-mediated mechanism
- 1 October 2020
- journal article
- letter
- Published by Elsevier in Brain, Behavior, and Immunity
- Vol. 89, 529-530
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Neuroleptic malignant syndrome in a COVID-19 patientBrain, Behavior, and Immunity, 2020
- Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemicThe Lancet Psychiatry, 2020
- Brain imaging in catatonia: systematic review and directions for future researchPsychological Medicine, 2020
- Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, ChinaIntensive Care Medicine, 2020
- Catatonia and the immune system: a reviewThe Lancet Psychiatry, 2019
- Cytokine effects on the basal ganglia and dopamine function: The subcortical source of inflammatory malaiseFrontiers in Neuroendocrinology, 2012
- Impaired striatal GABA transmission in experimental autoimmune encephalomyelitisBrain, Behavior, and Immunity, 2011
- What catatonia can tell us about “top-down modulation”: A neuropsychiatric hypothesisBehavioral and Brain Sciences, 2002